Occudo Quantitative Strategies LP Ionis Pharmaceuticals Inc Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $1.86 Million - $2.48 Million	-50,905 Reduced 82.54%	10,766 $476,000
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $1.96 Million - $2.65 Million	61,671 New	61,671 $2.28 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $796,302 - $987,116	-26,650 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $682,506 - $935,415	26,650 New	26,650 $811,000
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $257,738 - $386,698	-6,063 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $274,653 - $365,417	6,063 New	6,063 $343,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.